Issue 3/2021
Content (32 Articles)
Supportive and palliative care in hemato-oncology: how best to achieve seamless integration and subspecialty development?
Hon Wai Benjamin Cheng, Ka On Lam
Erythrocyte microRNAs: a tiny magic bullet with great potential for sickle cell disease therapy
Henu Kumar Verma, Yashwant Kumar Ratre, L. V. K. S. Bhaskar, Raffaella Colombatti
Skin changes in hairy cell leukemia
Ewa Robak, Dorota Jesionek-Kupnicka, Tadeusz Robak
The effect of curcumin on serum copper, zinc, and zinc/copper ratio in patients with β-thalassemia intermedia: a randomized double-blind clinical trial
Mohammadreza Saeidnia, Peyman Nowrouzi-Sohrabi, Mehran Erfani, Pooria Fazeli, Gholamhossein Tamaddon, Mehran Karimi
Effects of three months of treatment with vitamin E and N-acetyl cysteine on the oxidative balance in patients with transfusion-dependent β-thalassemia
Sezaneh Haghpanah, Nader Cohan, Mohammadreza Bordbar, Asghar Bazrafshan, Mehran Karimi, Soheila Zareifar, Sanaz Safaei, Azam Aramesh, Mohamad Moghadam, Saeid Amiri Zadeh Fard, Omid Reza Zekavat
Risk factors and predictors of treatment responses and complications in immune thrombocytopenia
Shin Yeu Ong, Chuen Wen Tan, Vajjhala Ramya, Aisyah A. Malik, Xiu Hue Lee, Jordan C. C. Hwang, Yong Yang, Heng Joo Ng, Lai Heng Lee
Antimicrobial prophylaxis in patients with immune thrombocytopenia treated with rituximab: a retrospective multicenter analysis
Simona Raso, Mariasanta Napolitano, Giulia Arrigo, Francesco Reale, Alessandro Lucchesi, Paolo Silimbani, Aurelio Maggio, Giuseppina Calvaruso, Ugo Consoli, Donato Mannina, Giulio Giordano, Marco Santoro, Vincenzo Accurso, Sergio Siragusa
Correction of iron deficiency in hospitalized heart failure patients does not improve patient outcomes
Ronak H. Mistry, Andrew Kohut, Patricia Ford
G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
Jihad G. Youssef, Faisal Zahiruddin, George Youssef, Sriram Padmanabhan, Joe Ensor, Sai Ravi Pingali, Youli Zu, Sandeep Sahay, Swaminathan P. Iyer
Hematologic changes predict clinical outcome in recovered patients with COVID-19
Jian Mao, Rong Dai, Rui-Chan Du, Yan Zhu, Li-Ping Shui, Xiao-Hua Luo
Nivolumab discontinuation and retreatment in patients with relapsed or refractory Hodgkin lymphoma
Liudmila V. Fedorova, Kirill V. Lepik, Natalia B. Mikhailova, Elena V. Kondakova, Yuri R. Zalyalov, Vadim V. Baykov, Elena V. Babenko, Andrey V. Kozlov, Ivan S. Moiseev, Boris V. Afanasyev
Acute lymphoblastic leukemia–like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients
Eman O. Rasekh, Randa Osman, Dalia Ibraheem, Youssef Madney, Enas Radwan, Abdallah Gameel, Ahmed Abdelhafiz, Azza Kamel, Sally Elfishawi
Watch-and-wait or immediate immunotherapy/immunochemotherapy in patients with phase IE primary pulmonary MALT lymphoma? A multicenter retrospective study
Wei Yan, Bin Wu, Ai-Jun Liao, Wei Yang, Hui-Han Wang
Novel tumour–infiltrating lymphocyte-related risk stratification based by flow cytometry for patients with de novo angioimmunoblastic T cell lymphoma
Qiqi Zhu, Xueqin Deng, Wenqing Yao, Zihang Chen, Yunxia Ye, Limin Gao, Wenyan Zhang, Weiping Liu, Sha Zhao
Treatment of relapsed/refractory multiple myeloma in the bortezomib and lenalidomide era: a systematic review and network meta-analysis
Leonardo Javier Arcuri, Andre Dias Americo
Utilization of radiation therapy in multiple myeloma: trends and changes in practice
Sikander Ailawadhi, Ryan Frank, Meghna Ailawadhi, Zahara Kanji, Prachi Jani, Mark Fiala, Mays Abdulazeez, Salman Ahmed, Chander Shekher Aggarwal, Sonikpreet Aulakh, David Hodge, Vivek Roy, Victoria R. Alegria, Aneel Paulus, Asher Chanan-Khan, Taimur Sher
A multicenter phase II study of intrabone single-unit cord blood transplantation without antithymocyte globulin
Tetsuya Nishida, Takeshi Kobayashi, Masashi Sawa, Shinichi Masuda, Yasuhiko Shibasaki, Tatsunori Goto, Noriko Fukuhara, Nobuharu Fujii, Kazuhiro Ikegame, Junichi Sugita, Takashi Ikeda, Yachiyo Kuwatsuka, Ritsuro Suzuki, Yuho Najima, Noriko Doki, Tomonori Kato, Yuichiro Inagaki, Yoshikazu Utsu, Nobuyuki Aotsuka, Masayoshi Masuko, Seitaro Terakura, Yasushi Onishi, Yoshinobu Maeda, Masaya Okada, Takanori Teshima, Makoto Murata
Possible nosocomial transmission of virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation
Yoshiyuki Onda, Junya Kanda, Nozomu Hanaoka, Mizuki Watanabe, Yasuyuki Arai, Masakatsu Hishizawa, Tadakazu Kondo, Kouhei Yamashita, Miki Nagao, Tsuguto Fujimoto, Akifumi Takaori-Kondo
Impact of donor and recipient Epstein-Barr Virus serostatus on outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis
Michalina Kołodziejczak, Lidia Gil, Rafael de la Camara, Jan Styczyński
Abatacept as salvage therapy in chronic graft-versus-host disease—a retrospective analysis
Tobias Wertheimer, Marius Dohse, Gabriel Afram, Daniela Weber, Martin Heidenreich, Barbara Holler, Anna-Sophia Kattner, Andreas Neubauer, Stephan Mielke, Per Ljungman, Ernst Holler, Wolfgang Herr, Matthias Edinger, Antonio Pérez Martínez, Matthias Fante, Daniel Wolff
Post-transplant ferritin level predicts outcomes after allogeneic hematopoietic stem cell transplant, independent from pre-transplant ferritin level
Warren Fingrut, Arjun Law, Wilson Lam, Fotios V. Michelis, Auro Viswabandya, Jeffrey H. Lipton, Rajat Kumar, Jonas Mattsson, Dennis Dong Hwan Kim
Haploidentical hematopoietic stem cell transplantation for patients with myeloid sarcoma: a single center retrospective study
Wen-Jing Yu, Yu-Qian Sun, Ting-Ting Han, Pei-Pei Ye, Xiao-Hui Zhang, Lan-Ping Xu, Kai-Yan Liu, Chen-Hua Yan, Xiao-Jun Huang, Yu Wang
Early autologous and allogeneic peripheral blood stem cell transplantation for adult patients with acute B and T cell precursor neoplasms: a 12-year single center experience
Normann Steiner, L. Brunelli, G. Hetzenauer, B. Lindner, G. Göbel, J. Rudzki, I. Peschel, M. Nevinny-Stickel, W. Nussbaumer, W. Mayer, L. Loacker, B. Kircher, E. Gunsilius, D. Wolf, D. Nachbaur
Venetoclax and donor lymphocyte infusion for early relapsed acute myeloid leukemia after allogeneic hematopoietic cell transplantation. A retrospective multicenter trial
Odelia Amit, Yael Bar On, Galit Perez, Liat Shargian-Alon, Moshe Yeshurun, Ron Ram
Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative
Francesc Bosch, Blanca Navarro, Marta Crespo, Miguel Alcoceba, Julio Bravo Sánchez, Barbara Tazón, Alicia Serrano, María García Álvarez, Lydia González Serrano, Pablo Alonso-Torres, Miguel Villanueva, Cristina Loriente, Pau Abrisqueta, Manel Peiró, José Antonio García-Marco, Marcos González, María José Terol
A rare cause of respiratory failure in acute myeloid leukaemia patient
F. Z. Lahlimi, I. Tazi
Coombs-negative hemolytic anemia and elevated plasma hemoglobin levels in COVID-19
Guido Lancman, Bridget K. Marcellino, Santiago Thibaud, Kevin Troy
Compassionate use of glasdegib in combination with low-dose cytarabine for relapsed, refractory acute myeloid leukemia or high-risk myelodysplastic syndrome
Márcio Tavares, Sérgio Chacim, José Mário Mariz
Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report
Hannah Schüller, Franziska Klein, Michael Lübbert, Eric Peter Prager
COVID-19 infection in patients with multiple myeloma: a German-Chinese experience from Würzburg and Wuhan
Xiang Zhou, Tao Bai, Katharina Meckel, Jun Song, Yu Jin, K. Martin Kortüm, Hermann Einsele, Xiaohua Hou, Leo Rasche
Repeated ruptures of corpus luteum in a female patient with alpha1-antitrypsin Pittsburgh
Xiao-Hua Luo, Yan Zhu, Li-Ping Shui, Qing Xiao, Lin Liu
Ixazomib and lenalidomide maintenance therapy in multiple myeloma
Ricardo D. Parrondo, Victoria Alegria, Vivek Roy, Taimur Sher, Asher A. Chanan-Khan, Sikander Ailawadhi